Epigenetics Institute, Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Center of Excellence in Environmental Toxicology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Comparative Pathology Core, Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Toxicology. 2023 Nov;499:153640. doi: 10.1016/j.tox.2023.153640. Epub 2023 Oct 6.
Environmental exposure to endocrine disrupting chemicals (EDCs) during critical periods of development is associated with an increased risk of metabolic diseases, including hepatic steatosis and obesity. Di-2-ethylhexyl-phthalate (DEHP) is an EDC strongly associated with these metabolic abnormalities. DEHP developmental windows of susceptibility are unknown yet have important public health implications. The purpose of this study was to identify these windows of susceptibility and determine whether developmental DEHP exposure alters hepatic metabolism later in life. Dams were exposed to control or feed containing human exposure relevant doses of DEHP (50 μg/kg BW/d) and high dose DEHP (10 mg/kg BW/d) from preconception until weaning or only exposed to DEHP during preconception. Post-weaning, all offspring were fed a control diet throughout adulthood. Using the Metabolon Untargeted Metabolomics platform, we identified 148 significant metabolites in female adult livers that were altered by preconception-gestation-lactation DEHP exposure. We found a significant increase in the levels of acylcarnitines, diacylglycerols, sphingolipids, glutathione, purines, and pyrimidines in DEHP-exposed female livers compared to controls. These changes in fatty acid oxidation and oxidative stress-related metabolites were correlated with hepatic changes including microvesicular steatosis, hepatocyte swelling, inflammation. In contrast to females, we observed fewer metabolic alterations in male offspring, which were uniquely found in preconception-only low dose DEHP exposure group. Although we found that preconception-gestational-lactation exposure causes the most liver pathology, we surprisingly found preconception exposure linked to an abnormal liver metabolome. We also found that two doses exhibited non-monotonic DEHP-induced changes in the liver. Collectively, these findings suggest that metabolic changes in the adult liver of offspring exposed periconceptionally to DHEP depends on the timing of exposure, dose, and sex.
在发育关键期暴露于环境内分泌干扰物(EDCs)与代谢性疾病(包括肝脂肪变性和肥胖)的风险增加有关。邻苯二甲酸二(2-乙基己基)酯(DEHP)是一种与这些代谢异常密切相关的 EDC。DEHP 的发育易感性窗口期尚不清楚,但具有重要的公共卫生意义。本研究的目的是确定这些易感窗口期,并确定发育过程中 DEHP 暴露是否会改变成年后的肝脏代谢。从受孕前到断奶,给予母鼠对照饲料或含有人类暴露相关剂量的 DEHP(50μg/kgBW/d)和高剂量 DEHP(10mg/kgBW/d),或仅在受孕前暴露于 DEHP。断奶后,所有后代在成年期均喂食对照饮食。使用 Metabolon 非靶向代谢组学平台,我们鉴定出 148 种在雌性成年肝脏中受孕前-妊娠-哺乳期 DEHP 暴露影响的显著代谢物。与对照组相比,DEHP 暴露的雌性肝脏中酰基肉碱、二酰甘油、神经鞘脂、谷胱甘肽、嘌呤和嘧啶的水平显著增加。这些与脂肪酸氧化和氧化应激相关的代谢物的变化与肝脏变化有关,包括微泡性脂肪变性、肝细胞肿胀、炎症。与雌性相比,我们在雄性后代中观察到较少的代谢改变,这些改变仅在仅孕前低剂量 DEHP 暴露组中发现。尽管我们发现孕前-妊娠-哺乳期暴露会导致最严重的肝脏病理,但我们惊讶地发现,孕前暴露与异常的肝脏代谢组有关。我们还发现,两种剂量均表现出非单调的 DEHP 诱导的肝脏变化。总之,这些发现表明,在成年期暴露于 DEHP 的后代的肝脏代谢变化取决于暴露的时间、剂量和性别。